Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual

Area of Science:

• Rheumatology
• Immunology
• Clinical Research

Background:

• Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with significant morbidity.
• Understanding factors contributing to disease damage is crucial for effective patient management.
• Minority populations, including Hispanic and African American individuals, often experience different disease trajectories.

Purpose of the Study:

• To identify predictors of disease damage in a multiethnic cohort of SLE patients.
• To analyze factors influencing damage accrual in early disease stages (<=5 years).
• To compare damage patterns across Hispanic, African American, and Caucasian SLE patients.

Main Methods:

• Longitudinal study of 172 SLE patients (Hispanic, African American, Caucasian) from the LUMINA cohort.
• Assessment of socioeconomic, demographic, clinical, immunologic, and behavioral variables at baseline and annually.
• Measurement of disease damage using the Systemic Lupus International Collaborating Clinics Damage Index (SDI) and disease activity with the Systemic Lupus Activity Measure.

Main Results:

• Half of the patients accrued no damage; Hispanics showed higher SDI scores at follow-up.
• Renal damage was more frequent in Hispanics and African Americans; integument damage in African Americans.
• Independent predictors of damage included age, corticosteroid use, ACR criteria, disease activity, and illness behaviors.

Conclusions:

• SLE damage can manifest early; Hispanics experience more rapid accrual.
• Disease-related factors (corticosteroids, ACR criteria, activity) and patient factors (age, behaviors) significantly influence damage.
• Early identification of risk factors is essential for mitigating long-term SLE damage.